Nalaganje...

RAS-MAPK in ALK targeted therapy resistance

The clinical success of ALK targeted therapy is limited by resistance. To identify rational co-targeting strategies to enhance clinical outcomes, we explored the molecular basis of ALK oncogene dependence in ALK gene rearrangement positive (ALK+) lung adenocarcinoma. We discovered that the RAS-RAF-M...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Cycle
Main Authors: Hrustanovic, Gorjan, Bivona, Trever G
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825705/
https://ncbi.nlm.nih.gov/pubmed/26654768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1096103
Oznake: Označite
Brez oznak, prvi označite!